Salguero, FJ; Garcia-Jimenez, WL; Lima, I; Seifert, K; (2018) Histopathological and immunohistochemical characterisation of hepatic granulomas in Leishmania donovani-infected BALB/c mice: a time-course study. Parasites & vectors, 11 (1). p. 73. ISSN 1756-3305 DOI: https://doi.org/10.1186/s13071-018-2624-z

Voak, AA; Standing, JF; Sepúlveda, N; Harris, A; Croft, SL; Seifert, K; (2018) Pharmacodynamics and cellular accumulation of amphotericin B and miltefosine in Leishmania donovani-infected primary macrophages. The Journal of antimicrobial chemotherapy. ISSN 0305-7453 DOI: https://doi.org/10.1093/jac/dky014

Koniordou, M; Patterson, S; Wyllie, S; Seifert, K; (2017) Snapshot profiling of anti-leishmanial potency of lead compounds and drug candidates against intracellular L. donovani amastigotes with focus on human derived host cells. Antimicrobial agents and chemotherapy, 61 (3). ISSN 0066-4804 DOI: https://doi.org/10.1128/AAC.01228-16

Meredith, EL; Kumar, A; Konno, A; Szular, J; Alsford, S; Seifert, K; Horn, D; Wilkinson, SR; (2017) Distinct activation mechanisms trigger the trypanocidal activity of DNA damaging prodrugs. Molecular microbiology. ISSN 0950-382X DOI: https://doi.org/10.1111/mmi.13767

Voak, AA; Harris, A; Qaiser, Z; Croft, SL; Seifert, K; (2017) Treatment of experimental visceral leishmaniasis with single-dose liposomal amphotericin B - pharmacodynamics and biodistribution at different stages of disease. Antimicrobial agents and chemotherapy, 61 (9). ISSN 0066-4804 DOI: https://doi.org/10.1128/AAC.00497-17

Kaur, H; Seifert, K; Hawkes, GE; Coumbarides, GS; Alvar, J; Croft, SL; (2015) Chemical and Bioassay Techniques to Authenticate Quality of the Anti-Leishmanial Drug Miltefosine. The American journal of tropical medicine and hygiene, 92 (6 Suppl). pp. 31-8. ISSN 0002-9637 DOI: https://doi.org/10.4269/ajtmh.14-0586

Riede, O; Seifert, K; Oswald, D; Endmann, A; Hock, C; Winkler, A; Salguero, FJ; Schroff, M; Croft, SL; Juhls, C; (2015) Preclinical safety and tolerability of a repeatedly administered human leishmaniasis DNA vaccine. Gene therapy, 22 (8). pp. 628-35. ISSN 0969-7128 DOI: https://doi.org/10.1038/gt.2015.35

Seifert, K; Juhls, C; Salguero, FJ; Croft, SL; (2015) Sequential chemo-immunotherapy of experimental visceral leishmaniasis using single low dose liposomal amphotericin B and a novel DNA vaccine candidate. Antimicrobial agents and chemotherapy, 59 (9). pp. 5819-23. ISSN 0066-4804 DOI: https://doi.org/10.1128/AAC.00273-15 Full text not available from this repository.

Das, S; Freier, A; Boussoffara, T; Das, S; Oswald, D; Losch, FO; Selka, M; Sacerdoti-Sierra, N; Schönian, G; Wiesmüller, KH; +10 more... Seifert, K; Schroff, M; Juhls, C; Jaffe, CL; Roy, S; Das, P; Louzir, H; Croft, SL; Modabber, F; Walden, P; (2014) Modular multiantigen T cell epitope-enriched DNA vaccine against human leishmaniasis. Science translational medicine, 6 (234). 234ra56. ISSN 1946-6234 DOI: https://doi.org/10.1126/scitranslmed.3008222 Full text not available from this repository.

Lamour, SD; Veselkov, KA; Posma, JM; Giraud, E; Rogers, ME; Croft, S; Marchesi, JR; Holmes, E; Seifert, K; Saric, J; (2014) Metabolic, Immune, and Gut Microbial Signals Mount a Systems Response to Leishmania major Infection. Journal of proteome research, 14 (1). pp. 318-329. ISSN 1535-3893 DOI: https://doi.org/10.1021/pr5008202 Full text not available from this repository.

Voak, AA; Seifert, K; Helsby, NA; Wilkinson, SR; (2013) Evaluating aziridinyl nitrobenzamide compounds as leishmanicidal prodrugs. Antimicrobial agents and chemotherapy, 58 (1). pp. 370-7. ISSN 0066-4804 DOI: https://doi.org/10.1128/AAC.01459-13 Full text not available from this repository.

Nicoletti, S; Seifert, K; Gilbert, IH; (2009) N-(2-hydroxypropyl)methacrylamide-amphotericin B (HPMA-AmB) copolymer conjugates as antileishmanial agents. International journal of antimicrobial agents, 33 (5). pp. 441-8. ISSN 0924-8579 DOI: https://doi.org/10.1016/j.ijantimicag.2008.10.013

Seifert, K; Perez-Victoria, FJ; Stettler, M; Sánchez-Cañete, MP; Castanys, S; Gamarro, F; Croft, SL; (2007) Inactivation of the miltefosine transporter, LdMT, causes miltefosine resistance that is conferred to the amastigote stage of Leishmania donovani and persists in vivo. International journal of antimicrobial agents, 30 (3). pp. 229-35. ISSN 0924-8579 DOI: https://doi.org/10.1016/j.ijantimicag.2007.05.007 Full text not available from this repository.

Perez-Victoria, FJ; Sanchez-Canete, MP; Seifert, K; Croft, SL; Sundar, S; Castanys, S; Gamarro, F; (2006) Mechanisms of experimental resistance of Leishmania to miltefosine: Implications for clinical use. Drug resistance updates, 9 (1-2). pp. 26-39. ISSN 1368-7646 DOI: https://doi.org/10.1016/j.drup.2006.04.001 Full text not available from this repository.

Walochnik, J; Duchêne, M; Seifert, K; Obwaller, A; Hottkowitz, T; Wiedermann, G; Eibl, H; Aspöck, H; (2002) Cytotoxic activities of alkylphosphocholines against clinical isolates of Acanthamoeba spp. Antimicrobial agents and chemotherapy, 46 (3). pp. 695-701. ISSN 0066-4804 DOI: https://doi.org/10.1128/AAC.46.3.695-701.2002 Full text not available from this repository.